These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7794362)

  • 1. Therapeutic approach to microvascular angina (syndrome X).
    Seery JP
    J Am Coll Cardiol; 1995 May; 25(6):1472-3. PubMed ID: 7794362
    [No Abstract]   [Full Text] [Related]  

  • 2. Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
    Ceccarelli SM; Chomienne O; Gubler M; Arduini A
    J Med Chem; 2011 May; 54(9):3109-52. PubMed ID: 21504156
    [No Abstract]   [Full Text] [Related]  

  • 3. Perhexiline and hypertrophic cardiomyopathy: a new horizon for metabolic modulation.
    Horowitz JD; Chirkov YY
    Circulation; 2010 Oct; 122(16):1547-9. PubMed ID: 20921436
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of selective beta-adrenergic blockade on insulin sensitivity and release in control subjects and in patients with angina and normal coronary arteries (syndrome X).
    Fragasso G; Cattaneo N; Locatelli M; Caumo A; Pagnotta P; Piatti P; Bonini P; Chierchia SL
    G Ital Cardiol; 1998 Jun; 28(6):623-9. PubMed ID: 9672774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac syndrome X].
    Vermel' AE
    Klin Med (Mosk); 2006; 84(6):5-9. PubMed ID: 16875060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology.
    Lim TK; Choy AJ; Khan F; Belch JJ; Struthers AD; Lang CC
    Cardiovasc Ther; 2009; 27(1):49-58. PubMed ID: 19207480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial insulin resistance in patients with syndrome X.
    Botker HE; Moller N; Schmitz O; Bagger JP; Nielsen TT
    J Clin Invest; 1997 Oct; 100(8):1919-27. PubMed ID: 9329954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolism and the hypertrophied heart of the elderly].
    Rupp H; Rupp TP; Maisch B
    Dtsch Med Wochenschr; 2005 Mar; 130(12):726-30. PubMed ID: 15776359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibitors versus AT1 blockers in the treatment of hypertension and syndrome X.
    Feldman R
    Can J Cardiol; 2000 Aug; 16 Suppl E():41E-44E. PubMed ID: 10906626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic strategy and prognosis in patients with syndrome X].
    Takeyama Y
    Nihon Rinsho; 2003 May; 61 Suppl 5():951-6. PubMed ID: 12809063
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity.
    Kuhajda FP; Ronnett GV
    Curr Opin Investig Drugs; 2007 Apr; 8(4):312-7. PubMed ID: 17458181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndrome X and diabetes: what is the mystery?
    Weiswasser JM; Nylen E; Arora S; Wakefield M; Sidawy AN
    Semin Vasc Surg; 2002 Dec; 15(4):216-24. PubMed ID: 12478496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of I1-selective agents in the management of syndrome X.
    de Luca N; Argengiano L; Izzo R; Guerrera L; Iovino GL; Trimarco B
    Rev Port Cardiol; 2000 Apr; 19 Suppl 2():II33-5. PubMed ID: 10874855
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesus.
    Shafrir E; Ziv E; Saha AK; Ruderman NB
    Diabetes Metab Res Rev; 2002; 18(3):217-23. PubMed ID: 12112940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndrome X.
    Sylvén C
    J Intern Med; 1993 Oct; 234(4):431-3. PubMed ID: 8409842
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of microalbuminuria in insulin resistant patients with angina pectoris and normal coronary arteries (syndrome X).
    Bøtker HE; Bagger JP; Schmitz O; Mogensen CE
    Diabete Metab; 1994; 20(5):501-2. PubMed ID: 7859900
    [No Abstract]   [Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache.
    Rosen ED; Spiegelman BM
    J Clin Invest; 2000 Sep; 106(5):629-31. PubMed ID: 10974014
    [No Abstract]   [Full Text] [Related]  

  • 18. [ACE inhibitor in metabolic syndrome].
    Hasslacher C
    Z Kardiol; 1994; 83 Suppl 4():21-9. PubMed ID: 7856277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic options for the management of patients with cardiac syndrome X.
    Kaski JC; Valenzuela Garcia LF
    Eur Heart J; 2001 Feb; 22(4):283-93. PubMed ID: 11161946
    [No Abstract]   [Full Text] [Related]  

  • 20. [X-syndrome: a pending problem].
    Marchese F; Davi R
    Clin Ter; 1994 Jan; 144(1):11-7. PubMed ID: 8168345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.